8 Results for "

DL-2-Amino-5-phosphonovaleric acid

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "DL-2-Amino-5-phosphonovaleric acid" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-100714
CAS No.: 76326-31-3
Purity:  ≥98.0%
Synonyms: 2-APV; DL-2-Amino-5-phosphonovaleric acid
Target:  

iGluR

DL-AP5 (2-APV) is a competitive NMDA (N-methyl-D-aspartate) receptor antagonist. DL-AP5 shows significantly antinociceptive activity. DL-AP5 specifically blocks on channels in the rabbit retina .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-100714C
CAS No.: 1303993-72-7
Purity:  99.20%
Synonyms: 2-APV sodium; DL-2-Amino-5-phosphonovaleric acid sodium
Target:  

iGluR

DL-AP5 (2-APV) sodium is a competitive NMDA (N-methyl-D-aspartate) receptor antagonist. DL-AP5 sodium shows significantly antinociceptive activity. DL-AP5 sodium specifically blocks on channels in the rabbit retina .
loading...
    loading...
Cat. No.: HY-P10341
CAS No.: 1345835-12-2
Target:  

GCGR

Research Areas:  

Metabolic Disease

ZP3022 is a dual agonist of glucagon-like peptide-1 (GLP-1) and gastrin that has the ability to sustainably improve glycemic control. Additionally, ZP3022 can effectively increase β-cell mass, promote β-cell proliferation, and enhance the function of pancreatic islets. ZP3022 can be used in anti-diabetic research .
loading...
    loading...
Cat. No.: HY-100714D
CAS No.: 125229-62-1
Synonyms: 2-APV lithium; DL-2-Amino-5-phosphonovaleric acid lithium
Target:  

iGluR

DL-AP5 (2-APV) lithium is a competitive NMDA (N-methyl-D-aspartate) receptor antagonist. DL-AP5 lithium shows significantly antinociceptive activity. DL-AP5 lithium specifically blocks on channels in the rabbit retina .
loading...
    loading...
Cat. No.: HY-100714CR
CAS No.: 1303993-72-7
Synonyms: 2-APV sodium (Standard); DL-2-Amino-5-phosphonovaleric acid sodium (Standard)
DL-AP5 (sodium) (Standard) is the analytical standard of DL-AP5 (sodium). This product is intended for research and analytical applications. DL-AP5 (2-APV) sodium is a competitive NMDA (N-methyl-D-aspartate) receptor antagonist. DL-AP5 sodium shows significantly antinociceptive activity. DL-AP5 sodium specifically blocks on channels in the rabbit retina .
loading...
    loading...
Cat. No.: HY-100714R
CAS No.: 76326-31-3
Synonyms: 2-APV (Standard); DL-2-Amino-5-phosphonovaleric acid (Standard)
DL-AP5 (Standard) is the analytical standard of DL-AP5. This product is intended for research and analytical applications. DL-AP5 (2-APV) is a competitive NMDA (N-methyl-D-aspartate) receptor antagonist. DL-AP5 shows significantly antinociceptive activity. DL-AP5 specifically blocks on channels in the rabbit retina .
loading...
    loading...
Cat. No.: HY-P11243
Target:  

Ephrin Receptor

Research Areas:  

Neurological Disease

EphA4 agonist compound 23 is a novel EphA4 agonist peptide mimic. EphA4 agonist compound 23 exhibits high affinity, high selectivity, and significant receptor activation ability. EphA4 agonist compound 23 is commonly used in the study of neurodegenerative diseases .
loading...
    loading...
Cat. No.: HY-P10876
Target:  

Amyloid-β

Research Areas:  

Neurological Disease

mcK6A1 is an inhibitor for the aggregation of amyloid-β (), that selectively binds to the 16KLVFFA21 segment of Aβ42, forms an extended β-folded structure, and inhibits the formation of Aβ42 oligomers. mcK6A1 can be used in research of Alzheimer's disease and other amyloid-related diseases .
loading...
    loading...